JP2016515583A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515583A5
JP2016515583A5 JP2016505557A JP2016505557A JP2016515583A5 JP 2016515583 A5 JP2016515583 A5 JP 2016515583A5 JP 2016505557 A JP2016505557 A JP 2016505557A JP 2016505557 A JP2016505557 A JP 2016505557A JP 2016515583 A5 JP2016515583 A5 JP 2016515583A5
Authority
JP
Japan
Prior art keywords
composition
med
bimatoprost
polymer
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016505557A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016515583A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/031955 external-priority patent/WO2014160828A1/en
Publication of JP2016515583A publication Critical patent/JP2016515583A/ja
Publication of JP2016515583A5 publication Critical patent/JP2016515583A5/ja
Pending legal-status Critical Current

Links

JP2016505557A 2013-03-27 2014-03-27 オキュラー・インサートおよびその使用方法 Pending JP2016515583A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361805895P 2013-03-27 2013-03-27
US61/805,895 2013-03-27
PCT/US2014/031955 WO2014160828A1 (en) 2013-03-27 2014-03-27 Bimatoprost ocular silicone inserts and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2016515583A JP2016515583A (ja) 2016-05-30
JP2016515583A5 true JP2016515583A5 (enExample) 2017-09-21

Family

ID=50896504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016505557A Pending JP2016515583A (ja) 2013-03-27 2014-03-27 オキュラー・インサートおよびその使用方法

Country Status (6)

Country Link
US (3) US20160022695A1 (enExample)
EP (1) EP2978406A1 (enExample)
JP (1) JP2016515583A (enExample)
AU (1) AU2014241201A1 (enExample)
CA (1) CA2907881A1 (enExample)
WO (1) WO2014160828A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8182840B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
AU2013334169B2 (en) 2012-10-26 2018-03-29 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
CA2968926C (en) * 2014-11-25 2023-01-17 Izhar Halahmi Compositions and methods for delivering a bio-active agent or bio-active agents
TW201642914A (zh) 2015-02-23 2016-12-16 組織科技股份有限公司 用於治療眼部疾病及失調的裝置及方法
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
WO2018169967A1 (en) 2017-03-14 2018-09-20 Allergan, Inc. Acorafloxacin in treating ocular infections
CA3110318A1 (en) 2018-08-21 2020-02-27 Allergan, Inc. The use of alpha-2-adrenergic receptor agonists for improving vision
US11077053B2 (en) 2018-08-21 2021-08-03 Allergan, Inc. Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
US11298537B2 (en) 2019-03-26 2022-04-12 Twenty Twenty Therapeutics Llc Non-invasive periocular device for dry-eye treatment and closed-loop methods for operating same
US11376432B2 (en) 2019-03-26 2022-07-05 Twenty Twenty Therapeutics Llc Non-invasive periocular device for dry-eye treatment
CN115443125A (zh) 2020-02-20 2022-12-06 阿勒根公司 α-2-肾上腺素能受体激动剂的药物组合物和其用于改善视力的用途
AU2021222048A1 (en) 2020-02-20 2022-10-13 Allergan, Inc. Alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and other ophthalmic purposes
JP7665645B2 (ja) * 2020-03-20 2025-04-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 局所的な薬物送達のための移植可能な薬物送達デバイス
CN114224822B (zh) * 2022-01-28 2023-07-14 复旦大学附属眼耳鼻喉科医院 一种眼部缓释给药植入物及其制造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452776A (en) * 1979-08-20 1984-06-05 Eye Research Institute Of Retina Foundation Hydrogel implant article and method
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
US7799336B2 (en) * 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8846073B2 (en) * 2006-12-19 2014-09-30 Allergan, Inc. Low temperature processes for making cyclic lipid implants for intraocular use
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
CN101984745B (zh) * 2007-09-07 2013-08-14 Qlt股份有限公司 用于持续释放治疗药物的药物核心
AU2009244804A1 (en) * 2008-05-09 2009-11-12 Qlt Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
ES2921527T3 (es) * 2009-06-03 2022-08-29 Forsight Vision5 Inc Administración de fármaco en segmento anterior
CN102050772B (zh) * 2009-11-02 2013-08-21 上海天伟生物制药有限公司 一种比马前列素晶体及其制备方法和用途
JP5989780B2 (ja) 2011-09-14 2016-09-07 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼挿入装置および方法

Similar Documents

Publication Publication Date Title
JP2016515583A5 (enExample)
Green et al. Inflammation and the developing brain: consequences for hippocampal neurogenesis and behavior
PH12019550009A1 (en) Photosensitive resin composition, cured film, laminate, method for producing cured film, method for producing laminate, and semiconductor device
Darke Opioid overdose and the power of old myths: what we thought we knew, what we do know and why it matters.
Mereddy et al. Benzoboroxoles: Synthesis and applications in medicinal chemistry
BR112014004155A2 (pt) método para fabricação de camada aditiva de objetos compreendendo mais de que um material com capacidade de forma livre para todos os materiais
MX2018000544A (es) Filamentos basados en un material de nucleo recubierto.
JP2015536739A5 (enExample)
EP2767535A4 (en) EPOXY COMPOUND WITH AN ALKOXYSILYL GROUP, METHOD FOR THE PRODUCTION, COMPOSITION AND HARDENED MATERIAL THEREWITH, AND USE THEREOF
WO2012000839A3 (en) Needle shield for a safety device, safety device and injection device
EP2692776A4 (en) ORGANOPOLYSILOXAN, PRODUCTION PROCESS THEREFOR, AND CURABLE COMPOSITION WITH THE ORGANOPOLYSILOXANE
JP2016081922A5 (ja) 電極、及び電極の作製方法
JP2015036247A5 (enExample)
EP2584619A3 (en) Encapsulating sheet and optical semiconductor element device
EP3348588A4 (en) DIENPOLYMER, METHOD FOR THE PRODUCTION OF A DIENOLYMER AND RUBBER COMPOSITION
EP3061586A4 (en) METHOD FOR THE PRODUCTION OF A RESIN COMPOSITE WITH A HARD COIL FILM AND A RESIN FOIL WITH A CARBIDE FILM
BR112017004469A2 (pt) material sorvente para separar bio-macromoléculas
MX2016008893A (es) Nanoparticulas magneticas funcionalizadas con catecol, produccion y uso de las misma.
JP2014051636A5 (enExample)
BR112016025235A2 (pt) homopoliéster, copoliéster, método de produção de um homopoliéster, método de produção de um copoliéster, processo de fabricação de um polímero de furanoato de poliisoidida, e utilização de um recipiente construído com o homopoliéster ou copoliéster
JP2017537998A5 (enExample)
MX2017015982A (es) Procedimiento para la preparacion de carbodiimidas polimericas con la adicion de sales de cesio, carbodiimidas polimericas y su uso.
EP2915832A4 (en) LACTID COPOLYMER, METHOD FOR ITS PREPARATION AND RESIN COMPOSITION THEREWITH
EP2868690A4 (en) THERMOPLASTIC POLYMER WITH A CARBON NANOMATEROLATED THEREFROM AND METHOD FOR THE PRODUCTION THEREOF
JP2014533769A5 (enExample)